23.70
price down icon2.95%   -0.72
after-market 시간 외 거래: 23.84 0.14 +0.59%
loading

Summit Therapeutics Inc (SMMT) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Operating Expenses
750.30%
568.44
66.85 65.82 58.11 59.78
Nonoperating Income/Loss
30.70%
2.729
3.938 13.10 2.124 -0.768
Income/Loss From Continuing Operations Before Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Income/Loss From Continuing Operations After Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Net Income/Loss
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Diluted Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Basic Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Diluted Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.61
price up icon 1.09%
$24.87
price down icon 0.96%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
자본화:     |  볼륨(24시간):